Fascin stain as a potential marker of invasiveness in carcinomas of the urinary bladder: A retrospective study with biopsy and cytology correlation

Diagnostic Cytopathology

Volumn 39, Issue 9, 2011, Pages 635-640

  McKnight, Ryan ^a   Cohen, Cynthia ^a   Siddiqui, Momin T ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

bladder biopsy; fascin; urine cytology; urothelial carcinoma

Indexed keywords

FASCIN;

ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLARY UROTHELIAL CARCINOMA; POORLY DIFFERENTIATED CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SMALL CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

BIOPSY; CARCINOMA; CARRIER PROTEINS; CELL NUCLEUS; HUMANS; MICROFILAMENT PROTEINS; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 80051765748     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21429     Document Type: Article

References (19)

1. Eble, JN, Sauter G, Epstein JI, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs. Lyon: IARC Press; 2005.
2. Droller MJ,. Bladder cancer: State-of-the-art care. CA Cancer J Clin 1998; 48: 269-284. (Pubitemid 28428769)
3. Bellmunt J, Albiol S, Kataja V, On behalf of the ESMO Guidelines Working Group. Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20: iv79-iv80.
4. Jimenez RE, Gheiler E, Oskanian P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000; 24: 980-987. (Pubitemid 30430485)
5. Thieblemont C, Fendler JP, Trillet-Lenoir V, et al. Prognostic factors of survival in infiltrating urothelial bladder carcinoma. A retrospective study of 158 patients treated by radical cystectomy. Bull Cancer 1996; 83: 139-146. (Pubitemid 26059133)
6. Hashimoto Y, Skacel M, Adams JC,. Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker? Int J Biochem Cell Biol 2005; 37: 1787-1804. (Pubitemid 40961664)
7. Tong G-X, Yee H, Chiriboga L, Hernandez O, Waisman J,. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol 2005; 36: 741-746. (Pubitemid 41112028)
8. Karasavvidou F, Barbanis S, Pappa D, et al. Fascin determination in urothelial carcinomas of the urinary bladder. Arch Pathol Lab Med 2008; 132: 1912-1915.
9. Bassi PF, De Marco V, De Lisa A, et al. Non-invasive diagnostic tests for bladder cancer: A review of the literature. Urologia Internationalis 2005; 75: 193-200. (Pubitemid 41433864)
10. Quek ML, Quinn DI, Daneshmand S, Stein JP,. Molecular prognostication in bladder cancer-A current perspective. Eur J Cancer 2003; 39: 1501-1510. (Pubitemid 36833219)
11. Vrooman OP, Witjes JA,. Molecular markers for detection, surveillance and prognostication of bladder cancer. Int J Urol 2009; 16: 234-243.
12. Sternberg SS, Mills SE, Carter D,. Sternberg's diagnostic surgical pathology. 5th ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins; 2010.
13. Piaton E, FaÃnel J, Hutin K, Ranchin M-C, Cottier M,. Conventional liquid-based techniques versus Cytyc Thinprep processing of urinary samples: A qualitative approach. BMC Clin Pathol 2005; 5: 1-7.
14. Yamashiro S, Yamakita Y, Ono S, Matsumura F,. Fascin, an actin-bundling protein induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 1998; 9: 993-1006. (Pubitemid 28457295)
15. Bakshi NA, Finn WG, Schnitzer B, Valdez R, Ross CW,. Fascin expression in diffuse large B-cell lymphoma. Anaplastic large cell lymphoma, and classical hodgkin lymphoma. Arch Pathol Lab Med 2007; 131: 742-747. (Pubitemid 46726135)
16. Durmaz A, Kurt B, Ongoru O, Karahatay S, Gerek M, Yalc NS,. Significance of fascin expression in laryngeal squamous cell carcinoma. J Laryngol Otol 2010; 124: 194-198.
17. Won KY, Kim GY, Lim S-J, Park Y-K, Kim YW,. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas. Pathol Res Practice 2009; 205: 742-748.
18. Zou J, Yang H, Chen F, et al. Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma. Eur J Cancer Prev 2010; 19: 11-17.
19. Lu DY, Nassar A, Siddiqui MT,. High-grade urothelial carcinoma: Comparison of SurePath liquid-based processing with cytospin processing. Diagn Cytopathol 2009; 37: 16-20.